Avacta is stepping up development of its peptide-drug conjugate (PDC), kicking off expansion cohorts in multiple tumor types ...

Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and Mitsubishi Tanabe with deals announced on ...

The new research focuses on a process called "conjugation," one of the main mechanisms for transferring DNA from one bacterium to another. During conjugation, one bacterial cell connects directly ...